BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24515341)

  • 1. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.
    Jagannath VA; Asokan GV; Fedorowicz Z; Lee TW
    Cochrane Database Syst Rev; 2014 Feb; (2):CD008139. PubMed ID: 24515341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.
    Jagannath VA; Asokan GV; Fedorowicz Z; Singaram JS; Lee TW
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008139. PubMed ID: 20238363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.
    Jagannath VA; Asokan GV; Fedorowicz Z; Lee TW
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008139. PubMed ID: 26905631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
    Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Innes S
    Cochrane Database Syst Rev; 2017 May; 5(5):CD006842. PubMed ID: 28471492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
    McIlwaine M; Button B; Dwan K
    Cochrane Database Syst Rev; 2015 Jun; (6):CD003147. PubMed ID: 26083308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee TW; Southern KW
    Cochrane Database Syst Rev; 2012 Oct; 10():CD005599. PubMed ID: 23076917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
    Thaker V; Haagensen AL; Carter B; Fedorowicz Z; Houston BW
    Cochrane Database Syst Rev; 2015 May; (5):CD008901. PubMed ID: 25991406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee TW; Southern KW
    Cochrane Database Syst Rev; 2013 Nov; (11):CD005599. PubMed ID: 24282073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for preventing influenza in people with cystic fibrosis.
    Dharmaraj P; Smyth RL
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD001753. PubMed ID: 24604671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Agnew J
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006842. PubMed ID: 25038719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee T; Southern KW
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
    Jefferson T; Jones M; Doshi P; Del Mar C; Dooley L; Foxlee R
    Cochrane Database Syst Rev; 2010 Feb; 2011(2):CD001265. PubMed ID: 20166059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
    Ng SM; Franchini AJ
    Cochrane Database Syst Rev; 2014 Jul; (7):CD003424. PubMed ID: 25019293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for preventing influenza in people with cystic fibrosis.
    Dharmaraj P; Smyth RL
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001753. PubMed ID: 19821281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
    Jefferson TO; Demicheli V; Di Pietrantonj C; Jones M; Rivetti D
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001265. PubMed ID: 16855962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis.
    Thornton J; Rangaraj S
    Cochrane Database Syst Rev; 2012 Mar; (3):CD006838. PubMed ID: 22419317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.